Ranolazine, Ethnicity and the Metabolic Syndrome

Clinical trial NCT01304095 · UNKNOWN

Trial details

NCT number: NCT01304095
Sponsor: Atlanta Heart Specialists, LLC
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Angina Metabolic Syndrome

Start date: 2011-01-01
Primary completion: 2013-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.